Inventprise

Inventprise company information, Employees & Contact Information

Explore related pages

Related company profiles:

At Inventprise, developing innovative and widely available vaccines is in our DNA. By producing targeted vaccines for populations worldwide, we're addressing global health inequalities and empowering people to live healthy lives—no matter where they live. Headquartered in Redmond, WA, our goal is to deliver widely-available, effective vaccines at large-scale to Low and Middle Income Countries, as well as populations in the U.S. and around the world. Inventprise is committed to creating a diverse and inclusive workplace, where our people are inspired to do their best work. We’re proud to have some of the world’s most qualified industry scientists, researchers, and manufacturing professionals on our team, and strive to create a vibrant, dynamic presence in the Washington State Life Sciences environment. Learn more about Inventprise and view open roles at www.inventprise.com/careers to become a part of our growing team.
Looking for a particular Inventprise employee's phone or email?

Inventprise Questions

News

Inventprise Announces Breakthrough in COVID-19 Conjugate Vaccine Study Published in Vaccine Journal - Yahoo Finance

Inventprise Announces Breakthrough in COVID-19 Conjugate Vaccine Study Published in Vaccine Journal Yahoo Finance

Serotype distribution of remaining invasive pneumococcal disease after extensive use of ten-valent and 13-valent pneumococcal conjugate vaccines (the PSERENADE project): a global surveillance analysis - The Lancet

Serotype distribution of remaining invasive pneumococcal disease after extensive use of ten-valent and 13-valent pneumococcal conjugate vaccines (the PSERENADE project): a global surveillance analysis The Lancet

Inventprise Announces Investment of up to $90 Million to Advance its 25 Valent Pneumococcal Conjugate Vaccine Candidate into Proof-of-Concept Clinical Trials - Business Wire

Inventprise Announces Investment of up to $90 Million to Advance its 25 Valent Pneumococcal Conjugate Vaccine Candidate into Proof-of-Concept Clinical Trials Business Wire

Inventprise completes dosing in Phase II pneumococcal vaccine study - Clinical Trials Arena

Inventprise completes dosing in Phase II pneumococcal vaccine study Clinical Trials Arena

Inventprise opens WA pneumococcal vaccine plant - BioProcess Insider - BioProcess International

Inventprise opens WA pneumococcal vaccine plant - BioProcess Insider BioProcess International

Seattle-area startup Inventprise gets backing from Gates Foundation for pneumonia shot - GeekWire

Seattle-area startup Inventprise gets backing from Gates Foundation for pneumonia shot GeekWire

25-Valent Pneumococcal Vaccine Candidate For Children Proceeds in Phase 2 - Vax-Before-Travel

25-Valent Pneumococcal Vaccine Candidate For Children Proceeds in Phase 2 Vax-Before-Travel

Gates Foundation commits up to $90M for Inventprise pneumococcal vax trials - MedCity News

Gates Foundation commits up to $90M for Inventprise pneumococcal vax trials MedCity News

The changing landscape of adult pneumococcal vaccines - Healio

The changing landscape of adult pneumococcal vaccines Healio

Gates Foundation Pours $90 Million into Promising New Pneumococcal Vaccine - BioSpace

Gates Foundation Pours $90 Million into Promising New Pneumococcal Vaccine BioSpace

Top Inventprise Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant